Results 41 to 50 of about 2,319 (150)
Global scope of glaucoma clinical practice for optometrists
Optometry and Vision Science, Volume 103, Issue 7, July 2026.ABSTRACT Purpose The role of optometrists in glaucoma care is evolving rapidly in many parts of the world. This review aims to describe the current global scope of clinical practice for optometrists with respect to glaucoma, highlighting progress and identifying barriers to care across diverse regions.
Jonathan Denniss +9 more
wiley +1 more source
, 2021 Brinzolamide is a topical carbonic anhydrase inhibitor which reduces the production of aqueous humor in the ciliary body, thereby reducing intra-ocular pressure. It is formulated as an ophthalmic suspension.
del Amo, Eva M +5 more
core +1 more source
Effects of 1% Topical Brinzolamide on Intraocular Pressure in Healthy Dogs [PDF]
, 2016 Background: Glaucoma is one of the most common causes of blindness in dogs, and is generally characterized by death of the retinal ganglion cells associated with a rapid loss of vision. Increased intraocular pressure (IOP) occurs in patients with primary
Maciel, Camila do Espirito Santo +7 more
core +3 more sources
Advancing Flexible Pressure Sensors for Next‐Generation Medical Monitoring
Advanced Sensor Research, Volume 5, Issue 6, June 2026.This review highlights recent advances in flexible pressure sensors for next‐generation medical monitoring. The sensing mechanisms, material and structural optimization strategies, and intelligent algorithms are systematically summarized. Emerging applications in cardiovascular, respiratory, neurological, laryngeal, and ocular disease monitoring are ...
Chunjun Su +4 more
wiley +1 more source
, 2011 Misha F Syed, Emma KR LoucksDepartment of Ophthalmology and Visual Sciences, The University of Texas Medical Branch, Galveston, TX, USAAbstract: Glaucoma encompasses a wide clinical spectrum of disease, with the common pathophysiology of progressive ...
Loucks EKR +3 more
core +1 more source
Clinical Ophthalmology, 2008 Thomas K Mundorf1, Steven H Rauchman2, Robert D Williams3, Ricardo Notivol4, Brinzolamide/Timolol Preference Study Group51Mundorf Eye Center, Charlotte, NC, USA; 2North Valley Eye Medical Group, Mission Hills, CA, USA; 3Taustine Eye Center, Louisville ...
Thomas K Mundorf +4 more
doaj
Innovative Drug Delivery Systems for the Treatment of Glaucoma
MedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.This review aims to provide a comprehensive overview of current topical drug delivery strategies for ocular hypotensive agents in glaucoma therapy. Additionally, it discusses the potential impact of emerging nanotechnological and biomaterial‐based systems in shaping the future of ophthalmic drug delivery, with an emphasis on enhancing efficacy, safety,
Jing Chu +9 more
wiley +1 more source
Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.ABSTRACT Objective To investigate responses to surgical interventions in concentrations of transforming growth factor‐β2 (TGF‐β2) and total protein (TP) in the aqueous humor (AH) of primary angle‐closure glaucoma (PACG) eyes, with and without Ahmed glaucoma valve surgery in dogs.
Songhui Lee, Kangmoon Seo, Seonmi Kang
wiley +1 more source
, 2004 Purpose: To compare the efficacy and safety of the concomitant administration of travoprost 0.004% once daily and brinzolamide 0.1% twice daily with those of a fixed combination of latanoprost 0.005%/timolol 0.5% once daily. Research, design and methods:
García Feijoo, Julián +5 more
core +1 more source
Ophthalmology and Therapy, 2023 Introduction The factors related to the ocular penetration of drugs after the administration of eye drops in humans have not been examined in detail. Therefore, this study assessed the influence of patient factors on the intraocular penetration of eye ...
Eriko Kunikane +3 more
doaj +1 more source